Brief: Selvita Unit Gets $4.7 Mln Order From US-Based Client
Jan 11 (Reuters) - Selvita SA SLVP.WA :
* SAID ON MONDAY THAT UNIT SELVITA INC. HAS RECEIVED ORDER
FROM
BIOTECHNOLOGY COMPANY BASED IN US WITHIN FRAMEWORK AGREEMENT
* UNDER ORDER THE UNIT IS TO PROVIDE SUPPORT FOR THE
CLIENT'S DRUG
DISCOVERY PLATFORM IN THE FIELD OF MEDICAL CHEMISTRY CONSISTING
IN THE SYNTHESIS OF CHEMICAL COMPOUNDS INDICATED BY THE CUSTOMER
* ORDER'S VALUE AT $4.7 MLN
Source text for Eikon: urn:newsml:reuters.com:*:nEM1nYcrva
Further company coverage: SLVP.WA
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys